United States · FDA National Drug Code directory
Naproxen Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-7800_e522f024-b4ac-4ff4-8368-e9e6da9eb37e
- Product NDC
- 68788-7800
- Form
- TABLET
- Composition / generic term
- Naproxen Sodium
- Labeler
- Preferred Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201013
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 550 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68788-7800-1) · 68788-7800-1
- 20 TABLET in 1 BOTTLE (68788-7800-2) · 68788-7800-2
- 30 TABLET in 1 BOTTLE (68788-7800-3) · 68788-7800-3
- 14 TABLET in 1 BOTTLE (68788-7800-4) · 68788-7800-4
- 60 TABLET in 1 BOTTLE (68788-7800-6) · 68788-7800-6
- 120 TABLET in 1 BOTTLE (68788-7800-8) · 68788-7800-8
- 90 TABLET in 1 BOTTLE (68788-7800-9) · 68788-7800-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →